Advances in the imaging and treatment of neovascular retinal disease are emerging rapidly, presenting opportunities for more precise and individualized care of patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Alongside these innovations, real-world data are helping to fill in gaps left by clinical trial data and highlight potential imaging-based best practices related to agent selection and dosing interval decisions. This activity illustrates the treatment effects guided by retina specialist imaging experts.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 523 Route 303
Pricing
97% of listed courses are free
34 of 35 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Communication & Shared Decision-Making
- Dermatology
- Gastroenterology
- General Pediatrics
- Hematology
- Medical Oncology
- Nephrology
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Psychotic Disorders
- Rheumatology
- Surgical Oncology
- Cross-Specialty
- GI & Liver
- Medical Subspecialties
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- Pediatrics
- Psychiatry
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
-
ReleasedJun 4, 2026
-
Last day to claim creditJun 5, 2027 8 months left
-
Physicians’ Education Resource (CME Track) Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension
-
PRIME Education, Inc. (PRIME®) Decisions That Matter: Applying Evidence to Intravitreal Therapies for Retinal Vascular Diseases
-
Vindico Medical Education, LLC Advances in Second-Generation Anti-VEGF Therapy for Retinal Disease
-
Paradigm Medical Communications, LLC Trials Vs Reality: Matching Clinical and Real-World Evidence With Second-Generation Retinal Therapies
-
Paradigm Medical Communications, LLC Reading Between the Lines: Nuanced Decision-Making With Sustained Delivery Therapies
-
Paradigm Medical Communications, LLC Delivering on the Promise of Sustained Treatment: Innovations in Long-Term Disease Control
